SB-639

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSB-639
Drug Alias NameSB-639
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1N/A
TargetsHistone deacetylase
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesS*BIO Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesS*BIO Pte Ltd
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A